TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI September 13, 1985